An observational study in Leukemia, Lymphocytic, Acute, sponsored by Stanford University. Completed at 1 site in United States. Open to participants aged Up to 18 Years. Per ClinicalTrials.gov, last updated 2010-03-02.
Sponsored by Stanford University · Observational
To determine if MRD (minimal residual disease) can be found in the blood (only) as opposed to bone marrow in children with ALL (acute lymphoblastic leukemia).
1,780 studies on the registry are indexed under Leukemia, Lymphoid; 176 are open to participants now.
This study's planned enrollment of 15 is below the median of 112 across 227 observational studies indexed under Leukemia, Lymphoid.
Browse Leukemia, Lymphoid studies →Stanford University is the lead sponsor of 2,117 studies on the registry; 425 are open to participants now.
Of its 259 completed or terminated interventional studies of FDA-regulated products, 197 (76%) have results posted.
Counted across the registry records on this site, refreshed daily.
children with newly diagnosed T-cell ALL
Inclusion Criteria:
This study is completed, as verified in Feb 2010. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Stanford University